ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   


 News | News By Subject | News By Date | Search News
Get Our Industry eNewsletter FREE email:    
 News By Date

SuMoTuWeThFrSa
303112345
6789101112
13141516171819
20212223242526
27282930123
45678910

 Thursday, April 24, 2014
 Top Breaking News
FDA Approves Janssen Biotech Inc. (JNJ)'s SYLVANT™ For Rare Castleman's Disease     More...
Merck & Co., Inc. (MRK) Announces Positive Outcome Of 3b Study For Kuvan     More...
 Featured Stories
Man Who Co-Discovered HIV Reveals Why There Won’t Be A Cure For AIDS     More...
Hips Don't Lie: Women With Wide Hips More Likely To Have A One Night Stand, University of Leeds Study     More...
Antimicrobial Ingredient In Health Products Spurs Growth Of Breast Cancer Cells, American Chemical Society Reveals     More...
Antibiotic-Resistant MRSA "Superbug" Found In U.S. Homes, Columbia University Medical Center Study     More...
Money May Carry 3,000 Different Types Of Bacteria, New York University Reveals     More...
 More News
Sunascen Therapeutics Gets FDA's Green Light For The New Over-The-Counter NAUS-EASE® Tablets     More...
Apricus Biosciences (APRI) Announces National Phase Approval For Vitaros® In Spain     More...
IntelGenx Corp. And RedHill Biopharma Ltd. (RDHL) Provide An Update On FDA's Ongoing Review Of The NDA For Migraine Versafilm™ Product     More...
Array BioPharma, Inc. (ARRY) Release: Binimetinib Continues To Advance In Clinical Development     More...
Bayer HealthCare Pharmaceuticals (BAYA.F) Release: Phase 3 DECISION Trial Of NEXAVAR (Sorafenib) In Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Cancer Refractory To Radioactive Iodine Published In The Lancet     More...
Durata Therapeutics, Inc.  (DRTX) Initiates Enrollment In A Phase 3b Study Of Dalvance™ In A 1500 Mg Single Dose     More...
Kamada Ltd. (KMDA.TA) Announces Significantly Improved Infusion Rate For Glassia®     More...
Progenics Pharmaceuticals, Inc. (PGNX) Announces The Completion Of Enrollment Of Chemotherapy Naive Cohort In Phase 2 Trial Of PSMA ADC     More...
Phase 2 Study Of Selinexor (KPT-330) Initiated By Karyopharm Therapeutics (KPTI) In Patients With Advanced Gynecologic Malignancies (SIGN Study)     More...
Teva Pharmaceutical Industries Limited (TEVA) Release: Pride-HD Study Enrolling Patients Globally To Further Evaluate Pridopidine For The Symptomatic Treatment Of Huntington’s Disease     More...
Vernalis PLC (VNLPY.PK): Promising Results Of Ph Ib/II POC Study In ADHD     More...
Cynapsus Therapeutics Announces Positive Results Of CTH-104 Clinical Study Of APL-130277 For Parkinson's Disease     More...
Alexion Pharmaceuticals Inc. (ALXN) Initiates Multinational Registration Trials Of Eculizumab As A Potential Treatment For Patients With Relapsing Neuromyelitis Optica (NMO) And Refractory Generalized Myasthenia Gravis (MG)     More...

 
    

//-->